Halozyme Therapeutics
HALO
YETI Holdings
YETI
eBay
EBAY
4
Workday
WDAY
5
Collegium Pharmaceutical
COLL
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 9.73%252.16M | -11.93%268.98M | -11.93%268.98M | -27.79%232.65M | -4.05%213.07M | 0.26%229.81M | 9.71%305.43M | 9.71%305.43M | 7.02%322.2M | -37.69%222.07M |
-Cash and cash equivalents | 9.73%252.16M | -11.93%268.98M | -11.93%268.98M | -27.79%232.65M | -4.05%213.07M | 0.26%229.81M | 9.71%305.43M | 9.71%305.43M | 7.02%322.2M | -37.69%222.07M |
Receivables | 5.58%10.55M | 1.04%10.05M | 1.04%10.05M | 7.83%9.47M | 16.15%9.57M | 19.03%10M | 12.63%9.95M | 12.63%9.95M | 12.80%8.78M | 12.00%8.24M |
-Accounts receivable | 5.58%10.55M | 1.04%10.05M | 1.04%10.05M | 7.83%9.47M | 16.15%9.57M | 19.03%10M | 12.63%9.95M | 12.63%9.95M | 12.80%8.78M | 12.00%8.24M |
Net loan | 3.81%2.1B | 4.21%2.06B | 4.21%2.06B | 5.51%2.04B | 5.13%2.03B | 6.05%2.02B | 4.04%1.97B | 4.04%1.97B | 3.68%1.93B | 5.72%1.93B |
-Gross loan | 3.78%2.12B | 4.18%2.08B | 4.18%2.08B | 5.48%2.06B | 5.10%2.05B | 6.02%2.04B | 4.04%1.99B | 4.04%1.99B | 3.71%1.95B | 5.75%1.95B |
-Allowance for loans and lease losses | 1.26%21.84M | 1.85%21.73M | 1.85%21.73M | 2.71%21.76M | 2.57%21.63M | 3.40%21.56M | 3.43%21.34M | 3.43%21.34M | 6.16%21.18M | 8.71%21.09M |
Securities and investments | 1.65%701.89M | -4.09%687.21M | -4.09%687.21M | 3.33%700.03M | -10.01%668.92M | -10.18%690.49M | -8.08%716.53M | -8.08%716.53M | -11.78%677.49M | -8.70%743.32M |
-Available for sale securities | 10,703.14%561.22M | 10,229.90%537.57M | 10,229.90%537.57M | 6.17%5.33M | -37.12%5.2M | -30.88%5.2M | -61.33%5.2M | -61.33%5.2M | 45.17%5.02M | 139.75%8.28M |
-Held to maturity securities | -6.92%129.69M | -6.68%131.8M | -6.68%131.8M | -6.47%134.15M | -6.65%136.82M | -6.75%139.33M | -6.89%141.24M | -6.89%141.24M | -7.31%143.42M | -8.14%146.57M |
-Short term investments | -97.99%10.98M | -96.87%17.85M | -96.87%17.85M | 5.96%560.56M | -10.47%526.89M | -10.76%545.97M | -7.21%570.09M | -7.21%570.09M | -13.24%529.05M | -9.62%588.48M |
Bank owned life insurance | 2.90%30.59M | 2.88%30.38M | 2.88%30.38M | 2.84%30.16M | 2.77%29.95M | 2.68%29.73M | 2.62%29.53M | 2.62%29.53M | 2.58%29.33M | 2.56%29.14M |
Net PPE | 1.67%61.65M | 2.40%62.17M | 2.40%62.17M | 0.48%60.51M | 2.41%60.88M | 2.63%60.63M | 3.75%60.72M | 3.75%60.72M | 5.50%60.22M | 5.12%59.45M |
-Gross PPE | 1.67%61.65M | 4.20%91.96M | 4.20%91.96M | 0.48%60.51M | 2.41%60.88M | 2.63%60.63M | 4.71%88.26M | 4.71%88.26M | 5.50%60.22M | 5.12%59.45M |
-Accumulated depreciation | ---- | -8.17%-29.79M | -8.17%-29.79M | ---- | ---- | ---- | -6.87%-27.54M | -6.87%-27.54M | ---- | ---- |
Goodwill and other intangible assets | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M | 0.00%1.55M |
Other assets | 0.08%32.97M | 3.55%33.43M | 3.55%33.43M | -15.02%31.29M | 6.69%34.45M | 4.17%32.94M | 4.42%32.29M | 4.42%32.29M | 7.00%36.82M | 7.68%32.29M |
Total assets | 3.68%3.19B | 0.66%3.15B | 0.66%3.15B | 1.16%3.1B | 0.70%3.05B | 1.41%3.07B | 1.50%3.13B | 1.50%3.13B | 0.21%3.07B | -3.01%3.03B |
Liabilities | ||||||||||
Total deposits | 2.91%2.83B | 0.11%2.81B | 0.11%2.81B | -0.46%2.75B | 1.97%2.72B | 0.53%2.75B | 0.11%2.8B | 0.11%2.8B | -1.31%2.76B | -6.53%2.66B |
Payables | -27.86%6.46M | -5.21%7.58M | -5.21%7.58M | 72.81%11.75M | 113.45%8.75M | 268.23%8.96M | 411.84%8M | 411.84%8M | 469.51%6.8M | 248.47%4.1M |
-Accounts payable | -27.86%6.46M | -5.21%7.58M | -5.21%7.58M | 72.81%11.75M | 113.45%8.75M | 268.23%8.96M | 411.84%8M | 411.84%8M | 469.51%6.8M | 248.47%4.1M |
Long term debt and capital lease obligation | -14.81%2.74M | -23.97%2.86M | -23.97%2.86M | -23.38%2.98M | -95.16%3.1M | -22.27%3.22M | -11.53%3.77M | -11.53%3.77M | -11.08%3.89M | 1,324.45%64.02M |
-Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --60M |
-Long term capital lease obligation | -14.81%2.74M | -23.97%2.86M | -23.97%2.86M | -23.38%2.98M | -22.79%3.1M | -22.27%3.22M | -11.53%3.77M | -11.53%3.77M | -11.08%3.89M | -10.66%4.02M |
Other liabilities | 14.57%18.24M | 26.52%14.3M | 26.52%14.3M | 14.37%15.57M | 13.18%13.05M | -0.43%15.92M | -7.16%11.3M | -7.16%11.3M | -4.11%13.62M | -1.08%11.53M |
Total liabilities | 2.85%2.85B | 0.17%2.83B | 0.17%2.83B | -0.24%2.78B | -0.08%2.74B | 0.73%2.77B | 0.28%2.82B | 0.28%2.82B | -1.14%2.78B | -4.31%2.74B |
Shareholders'equity | ||||||||||
Share capital | -14.31%38.71M | -29.89%38.66M | -29.89%38.66M | -28.66%41.4M | -24.96%44.41M | -24.44%45.18M | -8.18%55.14M | -8.18%55.14M | -3.36%58.03M | -1.44%59.19M |
-common stock | -14.31%38.71M | -29.89%38.66M | -29.89%38.66M | -28.66%41.4M | -24.96%44.41M | -24.44%45.18M | -8.18%55.14M | -8.18%55.14M | -3.36%58.03M | -1.44%59.19M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 15.53%2.87M | 15.37%2.78M | 15.37%2.78M | 15.26%2.68M | 15.21%2.59M | 15.21%2.49M | 15.28%2.41M | 15.28%2.41M | 15.54%2.33M | 15.88%2.25M |
Retained earnings | 10.73%348.09M | 10.35%338.55M | 10.35%338.55M | 10.29%329.86M | 10.32%321.72M | 10.99%314.35M | 11.65%306.8M | 11.65%306.8M | 12.82%299.08M | 14.18%291.63M |
Gains losses not affecting retained earnings | 10.11%-56.36M | 0.41%-60.25M | 0.41%-60.25M | 35.96%-49.62M | 11.42%-61.73M | 8.52%-62.7M | 15.00%-60.49M | 15.00%-60.49M | 7.47%-77.49M | -9.23%-69.69M |
Total stockholders'equity | 11.36%333.32M | 5.23%319.74M | 5.23%319.74M | 15.03%324.32M | 8.33%306.99M | 8.20%299.31M | 14.34%303.85M | 14.34%303.85M | 15.83%281.95M | 11.74%283.37M |
Total equity | 11.36%333.32M | 5.23%319.74M | 5.23%319.74M | 15.03%324.32M | 8.33%306.99M | 8.20%299.31M | 14.34%303.85M | 14.34%303.85M | 15.83%281.95M | 11.74%283.37M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |